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D
espite a large number of epidemiologic associ-
ations, clinical studies, and animal models, a
direct involvement of pathogens in the etiology
of human type 1 diabetes is still a matter of
critical debate. Human enteroviruses (HEV), such as cox-
sackievirus B (CVB) and echoviruses (EV), have been
associated with type 1 diabetes since the late 1960s (1) and
have been found in pancreatic isolates of type 1 diabetic
patients (2–4) (rev. in 5). However, there are several
difﬁculties hampering the conviction of HEV as inducers of
type 1 diabetes: 1) pancreatic biopsies are not done on a
regular basis in type 1 diabetic patients; 2) HEV infections
are frequently found in nondiabetic individuals and often
remain asymptomatic; 3) the clinical manifestation of type
1 diabetes may occur years to decades after infection
(virus infection as a “hit-and-run” event); 4) type 1 diabetic
patients as well as healthy individuals undergo multiple
virus infections throughout their lifetime, some of which
might even protect them from rather than induce autoim-
mune disease; and 5) genetic predispositions might cover
possible environmental (i.e., virus) factors.
In this issue of Diabetes, Schulte et al. (6) address the
mechanism by which HEV infection of human islets might
inﬂuence type 1 diabetes onset and/or progression. They
found that monocyte-derived dendritic cells (DCs) efﬁ-
ciently phagocytosed CVB3-infected human and porcine
islets. Phagocytosis of CVB3-infected islets induced the
expression of several interferon-stimulated genes (ISGs),
such the retinoic acid–inducible gene (RIG)-I–like heli-
cases, RIG-I and melanoma differentiation–associated
gene 5 (Mda5), in DCs. Further experiments with the
murine insulinoma cell line, Min6, revealed that CVB3-
infected cells induced an antiviral state that protected
ISG-expressing DCs from subsequent CVB3-infection (Fig.
1). The antiviral state of protected DCs was found to be
dependent on the presence of intracellular viral RNA,
required (unlike lipopolysaccharides-induced responses)
endosomal acidiﬁcation, and the expression of type I
interferons (6). Thus, DCs are being reprogrammed upon
phagocytosis of CVB3-infected islets and might therefore
inﬂuence the balance of effector (aggressive) and regula-
tory T-cells (Treg). The question is, however, in which
direction the immune balance is being shifted by entero-
virus infection. Interestingly, in mouse models different
enterovirus strains have been demonstrated to have oppo-
site effects on the outcome of type 1 diabetes. Several
studies demonstrate that CVB4 promotes type 1 diabetes
in nonobese diabetic (NOD) mice (7–9). In contrast, CVB3
seems to have dual effect on the outcome of type 1
diabetes in NOD mice by either promoting the disease or,
under certain circumstances, signiﬁcantly protecting from
type 1 diabetes (10). However, CVB3-mediated protection
of NOD mice was dependent on the viral dose, the CVB3
substrain, and the time of administration in relation to the
immunopathogenic process (5). However, there is no
epidemiological evidence suggesting that CVB4 strains are
more involved in human type 1 diabetes than other CVB
serotypes (5). Recently, it has been reported that in both
NOD as well as rat insulin promoter–lymphocytic chorio-
meningitis virus (RIP-LCMV) mice infection with CVB3
resulted in the upregulation of programmed death 1 ligand
1 (PD-L1) on lymphoid cells and an enhancement of
CD4CD25 regulatory T-cells (11). In concert, PD-L1
upregulation and Treg expansion protected CVB3-infected
mice from type 1 diabetes, indicating that CVB3 can
indeed display protective properties under certain condi-
tions in animal models. Such a protective effect would
support the hygiene theory, which postulates that allergies
and autoimmune diseases are less frequent in regions with
a poor hygienic status (12). An association of the inci-
dence of type 1 diabetes and enterovirus infections has
been found in several European populations, indicating
that countries with a low infection rate of enterovirus,
such as Finland or Sweden, have the highest incidences of
type 1 diabetes (13). Further, a comparison between
Finland and Russian Karelia, which have a similar genetic
backgrounds but different rates of enterovirus infection,
revealed an inverse correlation between the presence of
anti-enterovirus antibodies and type 1 diabetes incidence
(14). The concept of the hygiene theory has been veriﬁed
in several animal models including the RIP-LCMV model
for type 1 diabetes, which is dependent on virus infection
to induce disease (15). It was found that secondary virus
infection at a remote location when the destruction of the
-cells was already ongoing might recruit aggressive T-
cells away from the pancreas and subsequently reverse the
ongoing auto-destructive process in the islets of Langer-
hans (16). Since enhanced T-cell apoptosis has been found
within the infected tissue, such a remote location can be
considered a ﬁlter for potentially auto-aggressive T-cells
(17). However, one has to consider that secondary infec-
tion with another virus (Pichinde virus) has been demon-
strated to accelerate type 1 diabetes in the same mouse
model (18).
The ﬁnding by Schulte et al. (6) that innate immune
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DCs upon phagocytosis of CVB3-infected human islets pro-
vides insight into the mechanisms involved in the antiviral
defense. The data ﬁt well with previous results of the same
group demonstrating that uptake of enterovirus-infected
Vero cells induce an antiviral state in DCs (19). However, the
work neither implies initiation nor protection from type 1
diabetes. In order to establish an inducing or protective role
for such antiviral DCs, a detailed assessment of their func-
tional properties and the mechanistic interactions with either
aggressive or regulatory T-cells will be necessary. Of special
interest is the balance of islet antigen–speciﬁc aggressive
versus regulatory T-cells locally within the islets of Langer-
hans. It has been recently demonstrated in a T-cell receptor–
transgenic NOD mouse model that the vast majority of islet
inﬁltrating T-cells are indeed antigen-speciﬁc and that the
entry into the islet of Langerhans is regulated in an antigen-
dependent manner (20). Attraction of nonspeciﬁc bystander
lymphocytes seems to play only a minor role in the destruc-
tion of -cells. Direct infection of islet cells and subsequent
activation of DCs within the islets of Langerhans might
therefore directly inﬂuence the balance of antigen-speciﬁc
T-cells within the islets.
Thus, the question of whether enteroviruses are now
convicted as inducers of type 1 diabetes remains unan-
swered. The present study identiﬁes a mechanism by
which enterovirus-infected islets inﬂuence the local im-
mune balance. However, it is not clear whether such a
change will lead to induction of type 1 diabetes or, on the
contrary, might even protect the islets from autoimmune
destruction.
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